Home >> WEBINARS >> Current and emerging biomarkers: science, technologies, and practicalities

Current and emerging biomarkers: science, technologies, and practicalities

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenter Tabetha Sundin, PhD, HCLD, MB, Sentara Healthcare, Scientific Director, discusses advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This on-demand webinar originally broadcast on October 3, 2018.

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special grant from Bristol-Myers Squibb. IOUS1802863-01

x

Check Also

Homologous recombination deficiency and BRCA testing in ovarian and breast cancer

Webinar presenters Dana Chase, MD,  Michelle Shiller, DO, and Tabetha Sundin, PhD discuss the role of BRCA1/2 mutations in homologous recombination deficiency and carcinogenesis, homologous recombination deficiency as a marker of treatment sensitivity, the testing process for homologous recombination deficiency and BRCA mutations, and the role of BRCA testing in ovarian and breast cancer. This on-demand webinar originally broadcast on October 23, 2018.

X